Area of research
Molecular Biology · Oncology
Research interest
Research interests include Bone Metabolism and Diseases, Bone health and treatments, Bone health and osteoporosis research, and TGF-β signaling in diseases.
The role of the extracellular matrix protein SPOCK2 for bone physiology and hematopoiesis
Impact of mesenchymal stromal cell–derived vesicular cargo on B-cell acute lymphoblastic leukemia progression
Parathyroid hormone signaling in mature osteoblasts/osteocytes protects mice from age-related bone loss
Global transcriptomic analysis of a murine osteocytic cell line subjected to spaceflight
Emerging evidence that adaptive bone formation inhibition by non-steroidal anti-inflammatory drugs increases stress fracture risk
Glycerol-3-phosphate is an FGF23 regulator derived from the injured kidney
A FAK/HDAC5 signaling axis controls osteocyte mechanotransduction
Single-Cell RNA Sequencing of Calvarial and Long-Bone Endocortical Cells
TG-interacting factor 1 (Tgif1)-deficiency attenuates bone remodeling and blunts the anabolic response to parathyroid hormone
Vitamin K antagonism impairs the bone marrow microenvironment and hematopoiesis
A G protein–coupled, IP3/protein kinase C pathway controlling the synthesis of phosphaturic hormone FGF23
Osteocyte regulation of bone and blood
Loss of Gsα in osteocytes leads to osteopenia due to sclerostin induced suppression of osteoblast activity
Tributyltin induces distinct effects on cortical and trabecular bone in female C57Bl/6J mice
Myostatin inhibits osteoblastic differentiation by suppressing osteocyte-derived exosomal microRNA-218: A novel mechanism in muscle-bone communication
Autocrine and Paracrine Regulation of the Murine Skeleton by Osteocyte-Derived Parathyroid Hormone-Related Protein
Carbonic anhydrase III protects osteocytes from oxidative stress
Osteocyte secreted factors inhibit skeletal muscle differentiation
SIKs control osteocyte responses to parathyroid hormone
Osteocyte-Secreted Wnt Signaling Inhibitor Sclerostin Contributes to Beige Adipogenesis in Peripheral Fat Depots
The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro
HDAC5 Controls MEF2C-Driven Sclerostin Expression in Osteocytes
Differential regulation of myeloid leukemias by the bone marrow microenvironment
Plasma FGF23 levels increase rapidly after acute kidney injury
Estrogen receptor-α in osteocytes is important for trabecular bone formation in male mice
Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation
Intermittent parathyroid hormone administration converts quiescent lining cells to active osteoblasts
Serum Sclerostin Increases in Healthy Adult Men during Bed Rest